𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Monoclonal antibodies in immune and inflammatory diseases

✍ Scribed by Evangelos Andreakos; Peter C Taylor; Marc Feldmann


Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
70 KB
Volume
13
Category
Article
ISSN
0958-1669

No coin nor oath required. For personal study only.

✦ Synopsis


The era of monoclonal antibody-based therapeutics has arrived. Monoclonal antibodies of high quality targeting almost any antigen can now be engineered and manufactured in large quantities. In the clinic, monoclonal antibodies are proving to be safe and effective for the treatment of a wide range of diseases including rheumatoid arthritis, Crohn's disease, spondyloarthropathies, psoriasis and allograft rejection.


πŸ“œ SIMILAR VOLUMES


Monoclonal antibodies and their role in
✍ Dr. Myron Arlen; Kwong Y. Tsang πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 662 KB

Clinical studies in patients having been vaccinated with immunogenic glycoproteins suggest that a monoclonal antibody response is important in helping to induce cell mediated tumor destruction. Such a monoclonal response was noted to characterize the reaction to several different immunogenic antigen

Immunizations in patients with inflammat
✍ Ying Lu; Denise Jacobson; Athos Bousvaros πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 94 KB πŸ‘ 2 views

Patients receiving immunosuppressive therapies may be at increased risk for complications of vaccine preventable diseases, including influenza, varicella, and pneumococcus. However, studies suggest that patients with chronic illness may be inadequately immunized. In part, this is because of a paucit